Miyaguchi M, Sakai S, Takashima H, Hosokawa H
Department of Otolaryngology, Kagawa Medical School, Japan.
J Laryngol Otol. 1995 Apr;109(4):304-7. doi: 10.1017/s0022215100129986.
A retrospective analysis of 34 cases of sino-nasal squamous cell or undifferentiated carcinoma in patients admitted between 1984 and 1992 was undertaken. Multimodality therapy incorporated radiation, surgery and chemotherapy. The five-year survival rate was 53 per cent. The local control rate was 82 per cent. Patients died of local failure (six), distant metastases (six), lymph node metastases (one) and other causes (three). Twenty-eight patients with local control were separated into groups: G1-2 (well and moderately differentiated) and G3-4 (poorly differentiated and undifferentiated) and evaluated to find the association between differentiation and metastasis. Lymph node metastasis was not related to the degree of differentiation. Distant metastasis was significantly related to the degree of differentiation (Fisher's exact test: p = 0.007). The result of the combination therapy is poor for patients with poorly differentiated or undifferentiated carcinoma because of distant metastases. Adjuvant chemotherapy may be necessary for them to prevent distant metastasis.
对1984年至1992年间收治的34例鼻窦鳞状细胞癌或未分化癌患者进行了回顾性分析。多模式治疗包括放疗、手术和化疗。五年生存率为53%。局部控制率为82%。患者死于局部衰竭(6例)、远处转移(6例)、淋巴结转移(1例)和其他原因(3例)。28例局部控制的患者被分为G1-2组(高分化和中分化)和G3-4组(低分化和未分化),以评估分化与转移之间的关联。淋巴结转移与分化程度无关。远处转移与分化程度显著相关(Fisher精确检验:p = 0.007)。由于远处转移,低分化或未分化癌患者的联合治疗效果较差。辅助化疗可能对他们预防远处转移是必要的。